Cargando…

Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection

BACKGROUND: Cancer‐related inflammation has been correlated with cancer prognosis. This study evaluated inflammatory biomarkers, including neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR) and lymphocyte‐to‐monocyte ratio (LMR), programmed death ligand (PD‐L) 1 expression, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Itoh, S., Yugawa, K., Shimokawa, M., Yoshiya, S., Mano, Y., Takeishi, K., Toshima, T., Maehara, Y., Mori, M., Yoshizumi, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677099/
https://www.ncbi.nlm.nih.gov/pubmed/31388642
http://dx.doi.org/10.1002/bjs5.50170
_version_ 1783440885495627776
author Itoh, S.
Yugawa, K.
Shimokawa, M.
Yoshiya, S.
Mano, Y.
Takeishi, K.
Toshima, T.
Maehara, Y.
Mori, M.
Yoshizumi, T.
author_facet Itoh, S.
Yugawa, K.
Shimokawa, M.
Yoshiya, S.
Mano, Y.
Takeishi, K.
Toshima, T.
Maehara, Y.
Mori, M.
Yoshizumi, T.
author_sort Itoh, S.
collection PubMed
description BACKGROUND: Cancer‐related inflammation has been correlated with cancer prognosis. This study evaluated inflammatory biomarkers, including neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR) and lymphocyte‐to‐monocyte ratio (LMR), programmed death ligand (PD‐L) 1 expression, and tumour microenvironment in relation to prognosis and clinicopathological features of patients with hepatocellular carcinoma (HCC) undergoing curative hepatic resection. METHODS: Patients who had liver resection for HCC in 2000–2011 were analysed. Univariable and multivariable analyses were conducted for overall (OS) and recurrence‐free (RFS) survival. Immunohistochemical analyses of PD‐L1, CD8 and CD68 expression were performed. HCC cell lines were evaluated for PD‐L1 expression. A subgroup analysis was conducted to determine patient features, survival and the tumour microenvironment. Results were validated in a cohort of patients with HCC treated surgically in 2012–2016. RESULTS: Some 281 patients who underwent hepatic resection for HCC were included. Multivariable analysis showed that low LMR was an independent prognostic factor of OS (hazard ratio (HR) 1·59, 95 per cent c.i. 1·00 to 2·41; P = 0·045) and RFS (HR 1·47, 1·05 to 2·04; P = 0·022) after resection. Low preoperative LMR values were correlated with higher α‐fetoprotein values (P < 0·001), larger tumour size (P < 0·001), and high rates of poor differentiation (P = 0·035) and liver cirrhosis (P = 0·008). LMR was significantly lower in PD‐L1‐positive patients than in those with PD‐L1 negativity (P < 0·001). Results were confirmed in the validation cohort. PD‐L1 expression was upregulated in HCC cell lines treated with interferon‐γ and co‐cultured with THP‐1 monocyte cells. CONCLUSION: LMR is an independent predictor of survival after hepatic resection in patients with HCC. Modulation of the immune checkpoint pathway in the tumour microenvironment is associated with a low LMR.
format Online
Article
Text
id pubmed-6677099
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-66770992019-08-06 Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection Itoh, S. Yugawa, K. Shimokawa, M. Yoshiya, S. Mano, Y. Takeishi, K. Toshima, T. Maehara, Y. Mori, M. Yoshizumi, T. BJS Open Original Articles BACKGROUND: Cancer‐related inflammation has been correlated with cancer prognosis. This study evaluated inflammatory biomarkers, including neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR) and lymphocyte‐to‐monocyte ratio (LMR), programmed death ligand (PD‐L) 1 expression, and tumour microenvironment in relation to prognosis and clinicopathological features of patients with hepatocellular carcinoma (HCC) undergoing curative hepatic resection. METHODS: Patients who had liver resection for HCC in 2000–2011 were analysed. Univariable and multivariable analyses were conducted for overall (OS) and recurrence‐free (RFS) survival. Immunohistochemical analyses of PD‐L1, CD8 and CD68 expression were performed. HCC cell lines were evaluated for PD‐L1 expression. A subgroup analysis was conducted to determine patient features, survival and the tumour microenvironment. Results were validated in a cohort of patients with HCC treated surgically in 2012–2016. RESULTS: Some 281 patients who underwent hepatic resection for HCC were included. Multivariable analysis showed that low LMR was an independent prognostic factor of OS (hazard ratio (HR) 1·59, 95 per cent c.i. 1·00 to 2·41; P = 0·045) and RFS (HR 1·47, 1·05 to 2·04; P = 0·022) after resection. Low preoperative LMR values were correlated with higher α‐fetoprotein values (P < 0·001), larger tumour size (P < 0·001), and high rates of poor differentiation (P = 0·035) and liver cirrhosis (P = 0·008). LMR was significantly lower in PD‐L1‐positive patients than in those with PD‐L1 negativity (P < 0·001). Results were confirmed in the validation cohort. PD‐L1 expression was upregulated in HCC cell lines treated with interferon‐γ and co‐cultured with THP‐1 monocyte cells. CONCLUSION: LMR is an independent predictor of survival after hepatic resection in patients with HCC. Modulation of the immune checkpoint pathway in the tumour microenvironment is associated with a low LMR. John Wiley & Sons, Ltd 2019-04-29 /pmc/articles/PMC6677099/ /pubmed/31388642 http://dx.doi.org/10.1002/bjs5.50170 Text en © 2019 The Authors. BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Itoh, S.
Yugawa, K.
Shimokawa, M.
Yoshiya, S.
Mano, Y.
Takeishi, K.
Toshima, T.
Maehara, Y.
Mori, M.
Yoshizumi, T.
Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection
title Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection
title_full Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection
title_fullStr Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection
title_full_unstemmed Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection
title_short Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection
title_sort prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677099/
https://www.ncbi.nlm.nih.gov/pubmed/31388642
http://dx.doi.org/10.1002/bjs5.50170
work_keys_str_mv AT itohs prognosticsignificanceofinflammatorybiomarkersinhepatocellularcarcinomafollowinghepaticresection
AT yugawak prognosticsignificanceofinflammatorybiomarkersinhepatocellularcarcinomafollowinghepaticresection
AT shimokawam prognosticsignificanceofinflammatorybiomarkersinhepatocellularcarcinomafollowinghepaticresection
AT yoshiyas prognosticsignificanceofinflammatorybiomarkersinhepatocellularcarcinomafollowinghepaticresection
AT manoy prognosticsignificanceofinflammatorybiomarkersinhepatocellularcarcinomafollowinghepaticresection
AT takeishik prognosticsignificanceofinflammatorybiomarkersinhepatocellularcarcinomafollowinghepaticresection
AT toshimat prognosticsignificanceofinflammatorybiomarkersinhepatocellularcarcinomafollowinghepaticresection
AT maeharay prognosticsignificanceofinflammatorybiomarkersinhepatocellularcarcinomafollowinghepaticresection
AT morim prognosticsignificanceofinflammatorybiomarkersinhepatocellularcarcinomafollowinghepaticresection
AT yoshizumit prognosticsignificanceofinflammatorybiomarkersinhepatocellularcarcinomafollowinghepaticresection